Article By:
Benzinga
Sunday, October 10, 2021 6:00 PM EDT
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets amid the broader market strength.